Core Viewpoint - Bohai Chemical (600800.SH) announced that its wholly-owned subsidiary, Bohai Petrochemical, will extend the maintenance period for its PDH unit due to the need for equipment and utility system adjustments related to the acrylate and superabsorbent resin new material project, with production expected to resume by the end of February 2026 [1] Group 1 - Bohai Petrochemical's PDH unit requires coordination with new material projects [1] - The maintenance period for the PDH unit will be extended [1] - Production is anticipated to resume by the end of February 2026 [1]

Core Viewpoint - Baichuan Co., Ltd. (002455) announced on November 21 that its subsidiary, Ningxia New Materials, is investing in the construction of phosphate iron and lithium iron phosphate product projects, which have now entered the production phase [1] Company Summary - Baichuan Co., Ltd. is actively expanding its production capabilities in the new materials sector through its subsidiary [1] - The company is focusing on phosphate iron and lithium iron phosphate products, which are critical for various applications, including energy storage [1] Industry Summary - The investment in phosphate iron and lithium iron phosphate aligns with the growing demand for advanced materials in the energy sector [1] - The production phase indicates a shift towards operational capacity, potentially enhancing the company's market position in the new materials industry [1]

Core Points - The stock price of China Resources Materials has dropped by 5.04% on November 21, currently trading at 7.53 CNY per share, with a total market capitalization of 11.152 billion CNY [1] - The company has experienced a continuous decline for three days, with a cumulative drop of 3.41% during this period [1] Company Overview - China Resources Chemical Materials Technology Co., Ltd. is located in Changzhou, Jiangsu Province, and was established on July 14, 2003, with its listing date on October 26, 2021 [1] - The company's main business involves the research, development, production, and sales of polyester materials and new materials, with revenue composition being 82.77% from polyester products and 17.23% from raw materials and others [1] Shareholder Information - Among the top ten circulating shareholders of China Resources Materials, a fund under Southern Fund holds a position, specifically the Southern CSI 1000 ETF (512100), which increased its holdings by 6,100 shares in the third quarter, totaling 2.7227 million shares, representing 0.18% of circulating shares [2] - The estimated floating loss for the fund today is approximately 1.0891 million CNY, with a floating loss of 762,400 CNY during the three-day decline [2] - The Southern CSI 1000 ETF was established on September 29, 2016, with a current scale of 76.63 billion CNY, and has achieved a year-to-date return of 24.71% [2]

Core Viewpoint - The stock of Baihehua fell by 5.01% to 14.79 CNY per share, with a trading volume of 84.91 million CNY and a turnover rate of 1.36%, resulting in a total market capitalization of 6.158 billion CNY [1] Company Overview - Baihehua Group Co., Ltd. is located in Hangzhou, Zhejiang Province, established on August 11, 1995, and listed on December 20, 2016. The company specializes in the research, production, sales, and service of organic pigments, intermediates, and pearlescent pigments [1] - The revenue composition of the main business includes pigments at 89.33%, intermediates at 9.60%, and others at 1.06% [1] Shareholder Information - Southern Fund's Southern Zhihong Mixed A (020645) fund entered the top ten circulating shareholders of Baihehua in the third quarter, holding 2.1788 million shares, which accounts for 0.53% of the circulating shares. The estimated floating loss today is approximately 1.6994 million CNY [2] - The fund was established on August 2, 2024, with a latest scale of 325 million CNY. Year-to-date returns are 28.44%, ranking 2651 out of 8136 in its category; the one-year return is 31.3%, ranking 1896 out of 8056; and since inception, the return is 45.26% [2] Fund Manager Information - The fund manager of Southern Zhihong Mixed A is Jin Lanfeng, who has been in the position for 4 years and 186 days. The total asset scale of the fund is 1.589 billion CNY, with the best fund return during the tenure being 49.18% and the worst being 6.71% [3] Fund Holdings - Southern Zhihong Mixed A holds 2.1788 million shares of Baihehua, representing 4.27% of the fund's net value, making it the third-largest holding. The estimated floating loss today is approximately 1.6994 million CNY [4]

11月21日，湖北宜化跌5.1%，截至发稿，报15.44元/股，成交6.06亿元，换手率3.63%，总市值168.03亿 元。 南方中证1000ETF（512100）成立日期2016年9月29日，最新规模766.3亿。今年以来收益24.71%，同类 排名1906/4208；近一年收益18.97%，同类排名2143/3972；成立以来收益10.36%。 南方中证1000ETF（512100）基金经理为崔蕾。 截至发稿，崔蕾累计任职时间7年16天，现任基金资产总规模1227.6亿元，任职期间最佳基金回报 180.57%， 任职期间最差基金回报-15.93%。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建 议。 责任编辑：小浪快报 资料显示，湖北宜化化工股份有限公司位于湖北省宜昌市西陵区沿江大道52号，成立日期1993年9月6 日，上市日期1996年8月15日，公司主营业务涉及化肥、化工产品的生产与销售。主营业务收入构成 为：磷复肥26.07%，聚氯乙烯18.92%，尿素13.86 ...

Group 1 - The stock of Hongbo New Materials fell by 5.03% on November 21, closing at 6.61 CNY per share, with a trading volume of 1.04 billion CNY and a turnover rate of 2.37%, resulting in a total market capitalization of 4.297 billion CNY [1] - Hongbo New Materials, established on December 31, 2005, and listed on August 12, 2020, specializes in the research, production, and sales of functional silanes, nano-silicon materials, and other chemical additives, with its main business revenue composition being 82.81% from silane coupling agents, 11.79% from fumed silica, and 5.40% from other products [1] Group 2 - According to data from the top ten holdings of funds, one fund under Everbright Pramerica holds a significant position in Hongbo New Materials, specifically the Everbright Pramerica Anyang One-Year Mixed A Fund (012027), which held 170,000 shares as of the third quarter, accounting for 1.09% of the fund's net value, ranking as the seventh largest holding [2] - The Everbright Pramerica Anyang One-Year Mixed A Fund (012027) was established on June 17, 2021, with a current scale of 56.0715 million CNY, and has achieved a year-to-date return of 7.52%, ranking 6124 out of 8136 in its category, with a one-year return of 7.31%, ranking 6016 out of 8056, and a total return of 12.2% since inception [2]

Core Viewpoint - Hongyuan Pharmaceutical (301246.SZ) has a designed production capacity of 8,000 tons per year for lithium hexafluorophosphate products and holds a leading market share in the active pharmaceutical ingredient metronidazole, with products sold to dozens of countries and regions globally, establishing good partnerships with well-known pharmaceutical companies both domestically and internationally [1] Group 1 - The company has a designed production capacity of 8,000 tons per year for lithium hexafluorophosphate products [1] - The company holds a leading market share in metronidazole active pharmaceutical ingredients [1] - The company's products are sold to dozens of countries and regions globally [1] Group 2 - The company has established good partnerships with well-known pharmaceutical companies [1]

Core Viewpoint - The company has a designed production capacity of 8,000 tons per year for lithium hexafluorophosphate products and holds a leading market share in the active pharmaceutical ingredient metronidazole, with products sold to dozens of countries and regions globally, establishing strong partnerships with well-known pharmaceutical companies [1] Group 1 - The company has a designed production capacity of 8,000 tons per year for lithium hexafluorophosphate products [1] - The company holds a leading market share in metronidazole active pharmaceutical ingredients [1] - The company's products are sold to dozens of countries and regions globally [1] Group 2 - The company has established strong partnerships with well-known pharmaceutical companies [1]

Core Insights - The global titanium dioxide market is experiencing significant changes in supply and demand dynamics since 2010, influenced by factors such as shipping crises, tight capacity on China-US routes, and anti-dumping tariffs [1][3] - The company emphasizes the importance of strengthening raw material security, enhancing operational efficiency, developing high-end differentiated products, and expanding global presence to adapt to the changing market environment [3][5] Group 1 - The company is accelerating mineral resource integration at the upstream level to fortify raw material security [3] - At the production level, the company is deepening its operational excellence system to achieve cost reduction and efficiency improvement [3] - The company is committed to market-oriented research and development to break through high-end differentiated products [3] Group 2 - The company shared its short- to medium-term development plans and insights on the competitive landscape of the titanium industry during a global business leaders' roundtable [3] - The company views its overseas acquisition projects in titanium dioxide as a milestone for enhancing strategic layout and global service capabilities [3][5] - The company aims to integrate deeply into the global industrial chain, supply chain, and value chain collaborative network, focusing on key technological innovations and strategic industry collaboration [5]

恒邦股份（002237.SZ）11月20日在投资者互动平台表示，公司具备年产硫酸130万吨的能力，主要对外 销售，2024年硫酸自用量为15.09万吨。2025年上半年公司硫酸产量82.48万吨，收入2.4亿元，同比增长 383.80%。硫酸价格上涨对公司效益具有提振作用，未来硫酸价格变动会对公司业绩产生一定影响。 每经AI快讯，有投资者在投资者互动平台提问：尊敬的董秘，我看到贵公司上半年硫酸收入大增 383.80%，然后最近硫酸的价格也涨价，从年初每吨400多元涨到700多元了，贵司还有磷铵及其他化肥 业务，硫酸主要是自用还是销售？能有多少外售？贵司是否有受益于硫酸涨价？ （记者 张明双） ...